Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Victoria Stefaniak"'
Autor:
Stephen V. Liu, Misako Nagasaka, Victoria Stefaniak, Kristi Gruver, Yong Lin, David Ferry, Mark A. Socinski, Li Zhang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Sintilimab combined with pemetrexed and platinum met the primary endpoint of improving progression-free survival (PFS) as a first-line therapy for nonsquamous non-small cell lung cancer (NSCLC) in the phase 3 trial ORIENT-11 (NCT03607539). As seen in
Externí odkaz:
https://doaj.org/article/ba011ef8f8d944208052b2c5a41e42ae
Autor:
Li, Zhang, Zhehai, Wang, Jian, Fang, Qitao, Yu, Baohui, Han, Shundong, Cang, Gongyan, Chen, Xiaodong, Mei, Zhixiong, Yang, Victoria, Stefaniak, Yong, Lin, Shuyan, Wang, Wen, Zhang, Luyao, Sun, Yunpeng, Yang
Publikováno v:
Lung Cancer. 171:56-60
In ORIENT-11, first-line sintilimab + pemetrexed-platinum significantly improved PFS compared with placebo + pemetrexed-platinum in patients with advanced metastatic nonsquamous non-small-cell lung cancer (AMnsqNSCLC). The study met the primary endpo
Autor:
Misako Nagasaka, Cliff Molife, Zhanglin Lin Cui, Victoria Stefaniak, Xiaohong Li, Sangmi Kim, Hsui-Yung Lee, Julia Beyrer, George Blumenschein
Publikováno v:
Future Oncology. 18:1963-1977
Aim: This retrospective study estimated efficacy and safety of sintilimab + pemetrexed + platinum (SPP) versus placebo + pemetrexed + platinum (PPP) in untreated locally advanced/metastatic, nonsquamous non-small-cell lung cancer (NSCLC), after adjus